Chronic Pancreatitis Pain Market

Chronic Pancreatitis Pain Market - An Overview

The global chronic pancreatitis pain market is expected to witness strong growth during the forecast period between 2021 and 2031.

Pancreatitis is a medical condition of the inflammation of the pancreas. Chronic pancreatitis leads to long-lasting inflammation and is generally caused because of heavy alcohol consumption.

The primary symptom of chronic pancreatitis is constant pain experienced from the upper regions of the abdomen to the back. Aside that, some of the other symptoms include nausea, diabetes, vomiting, and weight loss owing to malabsorption of food.

Some of the tests performed to detect the presence of chronic pancreatitis include pancreas exocrine function tests, CT scans, endoscopic retrograde cholangiopancreatography, endoscopic ultrasound, and genetic testing.

COVID-19 pandemic negatively impacted the growth in the overall chronic pancreatitis pain market. With patients testing positive for the virus, key resources such as doctors and nurses were assigned for their treatment.

This led to reduced attention toward patients suffering from chronic pancreatitis and in turn, adversely affected the overall chronic pancreatitis pain market.

Chronic Pancreatitis Pain Market - Trends and Opportunities

Rising alcohol consumption among different population sections globally is the key growth driver for the chronic pancreatitis pain market.

Also, changing lifestyles among different population sections worldwide could contribute to the growth of the overall chronic pancreatitis pain market, in future.

Advancements in the medical industry with the launch of new products could contribute to the growth of the global chronic pancreatitis pain market, in the years ahead.

Government initiatives and measures that help in spreading awareness of the disease could help in the growth of the overall chronic pancreatitis pain market, in future.

Hospital end-use segment is expected to make the largest contribution to the overall chronic pancreatitis pain market in future owing to increasing number of patient admissions in hospitals, suffering from chronic pancreatitis pain.

Chronic Pancreatitis Pain Market - Competitive Landscape

The global chronic pancreatitis pain market is highly competitive and comprises many well-established market players. These players are expected to account for a large share in the overall market, in the coming years.

Leading chronic pain pancreatitis market players could engage in growth strategies such as novel product launches, in a bid to gain a competitive edge over other players.

Sun Biopharma developed a new line of therapeutic products a few years ago, with funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has been deployed in the treatment of pancreatic disorders.

Prominent chronic pancreatitis pain market players could collaborate with smaller players in a bid to expand their market presence and increase their revenue shares.

The smaller market players will seek investments from private investors, which could prove beneficial to them in the long term.

Some of the leading players in the global chronic pancreatitis pain market include McNeil Consumer Healthcare, Oxykem, Lonmin, and Sun Biopharma.

Chronic Pancreatitis Pain Market - Regional Assessment

The global chronic pancreatitis pain market is classified into five regions, namely, North America, Asia Pacific, Europe, Middle East and Africa, and Latin America.

North America is expected to be the dominant region in the global chronic pancreatitis pain market in future owing to increasing alcohol-consuming population in countries such as US and Canada.

Europe is anticipated to offer lucrative growth opportunities for the global chronic pancreatitis pain market because of rising population preferring to consume ready-to-eat products in countries such as UK and Germany.

Asia Pacific is expected to witness strong growth in the chronic pancreatitis pain market because of rising population in countries such as India and China.

Other parts of the world such as Latin America and Middle East and Africa are expected to witness moderate growth in the global chronic pancreatitis pain market, in future.